Home » Healthcare » Pharmaceuticals » Japan Periodontal Disease Market

Japan Periodontal Disease Market By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Type 4, Type 5); By Application (Non-surgical Treatment, Surgical Treatment, Application 3, Application 4, Application 5); By Therapeutics (Systematic Antibiotics, Local Antibiotics, Therapeutics 3, Therapeutics 4, Therapeutics 5); By End Users (Hospitals, Dental Clinics, Dental Academics, Research Institutes and Others, End Users 5); By Distribution Channel (Distribution Channel 1, Distribution Channel 2, Distribution Channel 3, Distribution Channel 4, Distribution Channel 5) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2699

Published: | Report ID: 66738 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Japan Periodontal Disease Market Size 2023  USD 182.12 Million
Japan Periodontal Disease Market, CAGR  6.41%
Japan Periodontal Disease Market Size 2032  USD 324.70 Million

Market Overview

The Japan Periodontal Disease Market is projected to grow from USD 182.12 million in 2023 to USD 324.70 million by 2032, at a compound annual growth rate (CAGR) of 6.41%.

The Japan periodontal disease market is driven by the rising prevalence of periodontal conditions, an aging population, and increased awareness about oral health. As the elderly population grows, there is a higher incidence of periodontal diseases, which drives demand for diagnostic and therapeutic treatments. Additionally, the adoption of advanced technologies in dental care, such as laser treatments and regenerative therapies, is contributing to market growth. Growing awareness campaigns about the importance of oral hygiene and its links to overall health have also prompted more people to seek treatment. Moreover, the increasing availability of specialized dental clinics and the incorporation of periodontal disease management into routine healthcare services further support market expansion.

The Japan periodontal disease market is characterized by a well-established healthcare infrastructure and a growing awareness of oral health. Key regions such as Kanto, Kansai, and Chubu are seeing significant demand for periodontal care due to the high concentration of healthcare facilities and dental clinics. The country’s aging population also contributes to the increasing prevalence of periodontal diseases, creating a steady demand for both surgical and non-surgical treatments. Leading players in the market include major pharmaceutical and dental care companies like DENTSPLY SIRONA Inc., Biolase, Inc., and Yoshida Dental Manufacturing Co., Ltd. These companies are actively involved in the development and distribution of advanced periodontal disease treatments and technologies. Additionally, local clinics and hospitals play a crucial role in providing treatment, with an emphasis on preventive care and innovative therapeutic solutions. The market is expected to expand as technological advancements in periodontal treatments continue to evolve.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The Japan periodontal disease market was valued at USD 1.2 billion in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2032.
  • Rising awareness about oral health and the increasing prevalence of periodontal diseases among the aging population are driving market growth.
  • The expansion of dental clinics and increasing availability of advanced periodontal treatments are also contributing to market development.
  • High treatment costs and limited access to advanced care in rural areas pose significant challenges to market growth.
  • The growth of cosmetic dentistry, which includes periodontal care, is a key factor in boosting market demand.
  • The Kanto and Kansai regions are the major markets for periodontal disease treatments, with high concentrations of healthcare facilities.
  • Technological advancements in periodontal treatments and the development of minimally invasive procedures offer significant growth opportunities in the market.

Market Drivers

Aging Population

Japan’s rapidly aging population is a key driver in the growth of the periodontal disease market. A significant proportion of the population is over the age of 65, making elderly individuals more susceptible to periodontal conditions due to natural aging processes and comorbidities. For instance, the World Health Organization (WHO) reports that Japan has the highest proportion of elderly people globally, with over 28% of its population aged 65 and above. As people age, they are more likely to experience oral health issues, including periodontal disease, which leads to an increased demand for periodontal care. This demographic shift emphasizes the need for both preventive and therapeutic solutions, further fueling market growth.

Increased Awareness

Growing awareness about the importance of oral health and its connection to overall systemic health is another crucial factor driving demand for periodontal treatments in Japan. Research has shown that untreated periodontal disease can contribute to a range of other health conditions, such as heart disease and diabetes. For instance, a study published in the Journal of Clinical Periodontology found a significant association between periodontal disease and cardiovascular conditions. As awareness about these links increases, more individuals are seeking preventive care and early intervention for periodontal issues. Public health campaigns and dental education initiatives have played a significant role in shifting public perception and encouraging proactive dental care.

Favorable Healthcare Policies and Infrastructure

Japan’s strong healthcare infrastructure, supported by government policies, plays a critical role in the growth of the periodontal disease market. Government reimbursement schemes for dental treatments and dental insurance coverage make periodontal care more affordable for the public. For instance, Japan’s universal health insurance system covers a wide range of dental treatments, making them accessible to a larger portion of the population. Additionally, Japan boasts a well-developed network of qualified periodontists and dentists, ensuring that patients have access to high-quality care. These favorable healthcare policies and the extensive infrastructure contribute to a robust market environment, promoting the availability of advanced periodontal treatments across the nation.

Technological Advancements

Advancements in dental technology are transforming periodontal care in Japan. The introduction of minimally invasive techniques, such as laser treatments and regenerative therapies, has made treatment more accessible, effective, and less painful for patients. These technologies enable quicker recovery times and more precise interventions, which have contributed to a growing preference for professional periodontal care over traditional methods. As these innovations continue to evolve, they are expected to drive further growth in the market, as patients and dental professionals increasingly embrace cutting-edge treatments.

Market Trends

Aging Population and Increased Awareness

Japan’s rapidly aging population is one of the primary drivers of the periodontal disease market. Older individuals are more susceptible to periodontal conditions due to weakened immune systems, decreased salivation, and reduced ability to maintain proper oral hygiene, all of which increase the risk of developing oral diseases. As Japan’s elderly population grows, the demand for periodontal care services continues to rise. In parallel, there is a growing public awareness of the connection between oral health and overall systemic health, which is boosting the demand for preventive and therapeutic treatments. Educational campaigns, media coverage, and public health initiatives have made the link between oral health and chronic conditions like heart disease and diabetes more widely understood. This heightened awareness has prompted more individuals to seek professional care for prevention, early detection, and treatment of periodontal disease, driving further market growth.

Technological Advancements, Healthcare Policies, and Lifestyle Factors

Technological advancements are also playing a significant role in the evolution of periodontal care in Japan. The development of advanced dental technologies, such as laser therapy and platelet-rich plasma (PRP) treatments, is improving the efficacy and accessibility of periodontal treatments. For instance, the use of laser-assisted periodontal therapy has been shown to significantly reduce treatment times and improve patient outcomes. Minimally invasive procedures are gaining popularity due to their shorter recovery times and reduced discomfort, making patients more inclined to opt for treatment. Furthermore, government policies supporting healthcare and reimbursement schemes for dental treatments have made periodontal care more affordable and accessible, encouraging patients to seek timely care. Japan’s well-established healthcare infrastructure, including a network of skilled periodontists and dentists, ensures that patients receive high-quality care, which is another key factor driving market growth. Additionally, lifestyle factors such as smoking, poor oral hygiene, and unhealthy diets contribute to the prevalence of periodontal disease. Addressing these factors through public health initiatives and promoting healthier lifestyle choices can help mitigate the disease’s impact. As more people become aware of the importance of maintaining good oral hygiene, the demand for periodontal treatments is likely to continue increasing, further bolstering the market.

Market Challenges Analysis

Aging Population and Healthcare Costs

While Japan’s aging population increases the demand for periodontal care, it also presents significant challenges. Elderly individuals often have multiple health conditions, which complicate treatment and require specialized care. Age-related factors, such as weakened immune systems and decreased oral hygiene, further exacerbate periodontal disease, making effective treatment more difficult. Additionally, the financial burden of treating elderly patients, particularly those with complex medical histories, can be considerable. Despite government support, healthcare costs, including dental care, can be high, and insurance coverage for periodontal treatments varies. This disparity in coverage may lead to financial stress for patients, making it difficult for some to access necessary care. These challenges highlight the need for comprehensive healthcare solutions that address both the clinical complexities and financial barriers associated with aging and periodontal disease treatment.

Patient Compliance, Early Detection, and Limited Access

Patient compliance remains a major challenge in managing periodontal disease, particularly when it comes to long-term maintenance. Factors such as busy lifestyles, fear of dental procedures, and a lack of awareness about the importance of consistent care can hinder adherence to treatment plans. Even though awareness of periodontal disease is growing, early detection and prevention are still critical to mitigating its impact. For instance, a study found that compliance with supportive periodontal therapy (SPT) is generally poor, with only 32% of patients fully adhering to their treatment plans. Encouraging regular dental check-ups and promoting better oral hygiene habits are essential in reducing the severity of the disease. Moreover, while Japan’s healthcare infrastructure is strong, access to specialized periodontal care can be limited, especially in rural areas. This geographic disparity often leads to delayed diagnosis and treatment, worsening the condition over time. Cultural and social factors, such as stigma surrounding dental issues, may also prevent individuals from seeking timely care. Overcoming these barriers is crucial for improving overall oral health outcomes and ensuring effective management of periodontal disease across Japan.

Market Opportunities

Expansion of Preventive and Early Intervention Services

One of the key market opportunities for periodontal disease treatment in Japan lies in the expansion of preventive and early intervention services. As awareness about the link between oral health and overall health continues to grow, there is increasing demand for regular check-ups, early detection, and proactive management of periodontal conditions. By promoting routine dental visits and encouraging early intervention, healthcare providers can help prevent the progression of periodontal disease, which is especially important given Japan’s aging population. Targeted educational campaigns and partnerships between healthcare providers and government agencies could further boost preventive care adoption, presenting a significant opportunity for the periodontal disease market to grow.

Advancements in Technology and Specialized Treatments

Another opportunity lies in the continued advancement of dental technologies and specialized periodontal treatments. Japan’s strong healthcare infrastructure and commitment to innovation create an environment conducive to the adoption of cutting-edge therapies, such as laser treatments, regenerative procedures, and minimally invasive techniques. These innovations not only improve treatment outcomes but also make care more accessible and less painful, appealing to a broader range of patients. Additionally, the growing interest in personalized medicine opens avenues for customized treatment plans, tailored to the individual needs of patients. By embracing these technological advancements, dental professionals in Japan can enhance their service offerings and attract more patients, driving market growth and establishing Japan as a leader in advanced periodontal care.

Market Segmentation Analysis:

By Type:

The Japan periodontal disease market is segmented by type into gingivitis, chronic periodontal disease, aggressive periodontal disease, Type 4, and Type 5. Gingivitis is the most common and mildest form of periodontal disease, typically treated with non-surgical interventions. Chronic periodontal disease, which affects a larger proportion of the population, often requires long-term management and may involve both surgical and non-surgical treatments. Aggressive periodontal disease, less common but more severe, affects younger individuals and demands intensive treatment to prevent tooth loss. Type 4 and Type 5 refer to rarer, more advanced stages of periodontal disease that require specialized care. The treatment approaches for these conditions vary, with chronic and aggressive periodontal disease often requiring a combination of non-surgical and surgical therapies, depending on the severity. The diversity within this segment allows for tailored treatment plans, which contribute to the growth and complexity of the market.

By Application:

The market is also segmented based on application, including non-surgical and surgical treatments. Non-surgical treatments, such as scaling, root planing, and the use of antimicrobial agents, are widely used, especially for milder forms of periodontal disease like gingivitis. These treatments are often sufficient for initial stages, contributing to a large market share. Surgical treatments, on the other hand, are necessary for more advanced stages, including chronic and aggressive periodontal diseases. Procedures like flap surgery, bone grafting, and soft tissue grafts are gaining popularity as patients seek more effective solutions for severe cases. Other emerging applications in this market include advanced laser treatments and regenerative therapies, which offer minimally invasive options with quicker recovery times. These innovative treatments are increasingly sought after, reflecting a shift toward more advanced, patient-friendly care options. As the demand for these specialized treatments grows, they present significant opportunities for the expansion of the periodontal disease market in Japan.

Segments:

Based on Type:

  • Gingivitis
  • Chronic Periodontal Disease
  • Aggressive Periodontal Disease
  • Type 4
  • Type 5

Based on Application:

  • Non-surgical Treatment
  • Surgical Treatment
  • Application 3
  • Application 4
  • Application 5

Based on Therapeutics:

  • Systematic Antibiotics
  • Local Antibiotics
  • Therapeutics 3
  • Therapeutics 4
  • Therapeutics 5

Based on End Users:

  • Hospitals
  • Dental Clinic
  • Dental Academics
  • Research Institutes and Others
  • End Users 5

Based on Distribution Channel:

  • Distribution Channel 1
  • Distribution Channel 2
  • Distribution Channel 3
  • Distribution Channel 4
  • Distribution Channel 5

Based on the Geography:

  • Kanto Region
  • Kansai Region
  • Chubu Region
  • Kyushu Region
  • Other Regions

Regional Analysis

Kanto region

The Kanto region, which includes Tokyo, the capital city of Japan, holds the largest market share in the periodontal disease market. As the most populous and economically developed region, Kanto accounts for a significant proportion of the country’s healthcare expenditures, including dental care. The region’s large urban population, high concentration of healthcare facilities, and advanced medical technologies contribute to its dominance in the periodontal disease market. In 2023, Kanto is estimated to hold approximately 40% of the total market share, driven by increased awareness, access to high-quality dental services, and advanced treatment options. The presence of leading dental hospitals and specialized periodontal centers in Tokyo ensures that residents have access to cutting-edge care, fostering demand for both preventive and advanced periodontal treatments. Furthermore, the high-income demographics and a large percentage of elderly individuals within the region further drive the market for periodontal disease management. The growing trend of health-conscious urban populations, combined with strong government and private healthcare infrastructure, positions Kanto as the most lucrative region for periodontal disease care in Japan.

Kansai Region

The Kansai region, which includes Osaka, Kyoto, and Kobe, is the second-largest market for periodontal disease treatment in Japan, holding around 30% of the market share. Known for its rich cultural heritage and high population density, Kansai’s periodontal disease market is fueled by the region’s urbanized nature and a rapidly aging population. Osaka, as the economic hub of the region, has a high demand for both general and specialized dental treatments, contributing significantly to the market’s growth. Despite its smaller population compared to Kanto, Kansai benefits from a robust healthcare infrastructure, including numerous dental clinics, private practices, and hospitals that provide both non-surgical and surgical treatments for periodontal conditions. Moreover, Kansai’s focus on public health initiatives and dental education has led to greater awareness about periodontal disease and its impact on overall health, driving demand for preventive care and early intervention. The growing adoption of innovative treatment options, such as laser therapies and regenerative treatments, further boosts the market in this region. Overall, the Kansai region’s well-developed healthcare sector and aging demographic make it a significant player in the periodontal disease market, with consistent growth expected over the forecast period.

Key Player Analysis

  • Bausch Health Companies Inc
  • Yoshida Dental Manufacturing Co., Ltd.
  • Tokyo International Clinic
  • Lyne Laboratories
  • WOCKHARDT
  • DENTSPLY SIRONA Inc
  • 3M
  • Amyndas Pharmaceuticals
  • Biolase, Inc
  • Company 10
  • Company 11
  • Company 12
  • Company 13
  • Company 14

Competitive Analysis

The competitive landscape of the Japan periodontal disease market is marked by the presence of several prominent players, each contributing to the growth and development of the industry. Leading companies such as Bausch Health Companies Inc., Yoshida Dental Manufacturing Co., Ltd., Tokyo International Clinic, Lyne Laboratories, WOCKHARDT, DENTSPLY SIRONA Inc., 3M, Amyndas Pharmaceuticals, Biolase, Inc., and others are actively involved in offering a wide range of periodontal disease treatments and therapies. Companies in this market are focusing on technological advancements and product innovations, such as laser therapies, non-surgical treatments, and antibiotic-based solutions, to address the growing demand for effective periodontal disease management. Strategic initiatives, including mergers, acquisitions, and new product launches, have helped businesses strengthen their market presence. The market is also witnessing increased collaboration between manufacturers and dental clinics, ensuring greater accessibility to advanced treatments. Moreover, the shift towards cosmetic dentistry and the growing awareness about oral health are driving the demand for periodontal care. Companies are emphasizing differentiated offerings, such as personalized treatment plans and minimally invasive procedures, to cater to the diverse needs of patients. As the market grows, there is a strong focus on educating consumers and healthcare professionals, further intensifying competition. The continued evolution of dental technologies and an expanding customer base contribute to the competitive intensity within the industry.

Recent Developments

  • In September 2023, Bausch Health Companies Inc. and its oral health care division, OraPharma announced plans to team up with the League of United Latin American Citizens (LULAC), the biggest Hispanic group in the U.S. Their goal is to spread awareness about gum disease among Hispanic communities. This collaboration aims to help Hispanics better understand how to detect and treat gum disease.
  • In June 2023, Eli Lilly and Company finalized an agreement to acquire DICE Therapeutics, Inc., a renowned biopharmaceutical firm recognized for its groundbreaking DELSCAPE technology platform. This platform is instrumental in creating novel oral therapeutic candidates, such as oral IL-17 inhibitors, which are presently in clinical development. These treatments are designed to target chronic immune-related diseases.
  • In March 2023, Haleon initiated the #BetterOralCareNation campaign in Malaysia to enhance oral health practices across the country. The campaign seeks to raise awareness about the importance of oral hygiene and promote better oral care habits among Malaysians.
  • In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.
  • In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.
  • In February 2022, Envista Holding Corporation formed a strategic partnership with the Spanish Dental Service Organization- Vitaldent Group. This helps the company to become the preferred supplier of dental implants.

Market Concentration & Characteristics

The Japan periodontal disease market exhibits a moderately concentrated structure, with a mix of established players and emerging entities vying for market share. This market is characterized by the increasing adoption of advanced diagnostic tools and treatment methods, which are driven by growing consumer awareness and rising demand for effective oral health solutions. Market participants are strategically focusing on innovation, leveraging minimally invasive techniques and advanced therapeutics to cater to diverse patient needs. The presence of specialized clinics and well-developed healthcare infrastructure further supports the competitive dynamics. Despite the dominance of a few established companies, smaller and regional players are carving out niches by offering tailored solutions and localized services. The market also reflects characteristics of high regulatory oversight, emphasizing quality standards and patient safety, which influence product development and market entry strategies. Collaborations between dental care providers and technology developers are fostering advancements in treatment modalities. Additionally, a noticeable trend is the integration of cosmetic dentistry with periodontal treatments, which broadens the market’s appeal. While competition remains robust, a shared emphasis on addressing the growing prevalence of periodontal diseases ensures consistent growth opportunities across the sector. The market’s dynamic nature underscores its ability to adapt to evolving consumer and healthcare demands.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Report Coverage

The research report offers an in-depth analysis based on Type, Application, Therapeutics, End Users, Distribution Channel and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The market for periodontal disease in Japan is expected to grow steadily due to increased awareness about oral health.
  2. Advancements in diagnostic technologies will enhance early detection and improve treatment outcomes.
  3. Rising adoption of minimally invasive and non-surgical treatment options will drive market growth.
  4. Integration of AI and digital tools in dental practices will streamline procedures and improve patient experiences.
  5. Collaboration between healthcare providers and technology companies will foster innovation in periodontal care.
  6. A growing focus on preventive care will encourage the adoption of personalized treatment plans.
  7. Expansion of cosmetic dentistry will align with periodontal treatments to meet aesthetic and health-related demands.
  8. Increased government and private sector investment in oral healthcare will support market development.
  9. The aging population in Japan will lead to higher demand for periodontal disease treatments.
  10. Regulatory updates emphasizing quality and safety will shape product innovation and market dynamics.

CHAPTER NO. 1 : INTRODUCTION 21
1.1.1. Report Description 21
Purpose of the Report 21
USP & Key Offerings 21
1.1.2. Key Benefits for Stakeholders 21
1.1.3. Target Audience 22
1.1.4. Report Scope 22
CHAPTER NO. 2 : EXECUTIVE SUMMARY 23
2.1. PERIODONTAL DISEASE Market Snapshot 23
2.1.1. Japan PERIODONTAL DISEASE Market, 2018 – 2032 (USD Million) 24
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 25
3.1. Russia-Ukraine and Israel-Palestine War Impacts 25
CHAPTER NO. 4 : PERIODONTAL DISEASE MARKET – INDUSTRY ANALYSIS 26
4.1. Introduction 26
4.2. Market Drivers 27
4.2.1. Rising trend of cosmetic dentistry will be boosting the market in a positive way 27
4.2.2. Increasing number of clinics providing periodontal care will grow the market 28
4.3. Market Restraints 29
4.3.1. High treatment costs and limited access to advance treatment will impact the growth negatively 29
4.4. Market Opportunities 30
4.4.1. Market Opportunity Analysis 30
4.5. Porter’s Five Forces Analysis 31
4.6. Value Chain Analysis 32
4.7. Buying Criteria 33
CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 34
5.1. Import Analysis by Japan 34
5.1.1. Japan PERIODONTAL DISEASE Market Import Volume/Revenue, By Japan, 2018 – 2023 34
5.2. Export Analysis by Japan 35
5.2.1. Japan PERIODONTAL DISEASE Market Export Volume/Revenue, By Japan, 2018 – 2023 35
CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 36
6.1. Demand Analysis by Japan 36
6.1.1. Japan PERIODONTAL DISEASE Market Demand Volume/Revenue, By Japan, 2018 – 2023 36
6.2. Supply Analysis by Japan 37
6.2.1. Japan PERIODONTAL DISEASE Market Supply Volume/Revenue, By Japan, 2018 – 2023 37
CHAPTER NO. 7 : PRODUCTION ANALYSIS 38
7.1. Production Analysis by Japan 38
7.1.1. Japan PERIODONTAL DISEASE Market Production Volume/Revenue, By Japan, 2018 – 2023 38
CHAPTER NO. 8 : PRICE ANALYSIS 39
8.1. Price Analysis by Type 39
8.1.1. Japan PERIODONTAL DISEASE Market Price, By Type, 2018 – 2023 39
8.1.2. Japan Type Market Price, By Type, 2018 – 2023 39
CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 40
9.1. Key Raw Materials and Suppliers 40
9.2. Key Raw Materials Price Trend 40
CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 41
10.1. Manufacturing Cost Analysis 41
10.2. Manufacturing Process 41
CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 42
11.1. Company Market Share Analysis – 2023 42
11.1.1. Japan PERIODONTAL DISEASE Market: Company Market Share, by Volume, 2023 42
11.1.2. Japan PERIODONTAL DISEASE Market: Company Market Share, by Revenue, 2023 43
11.1.3. Japan PERIODONTAL DISEASE Market: Top 6 Company Market Share, by Revenue, 2023 43
11.1.4. Japan PERIODONTAL DISEASE Market: Top 3 Company Market Share, by Revenue, 2023 44
11.2. Japan PERIODONTAL DISEASE Market Company Volume Market Share, 2023 45
11.3. Japan PERIODONTAL DISEASE Market Company Revenue Market Share, 2023 46
11.4. Company Assessment Metrics, 2023 47
11.4.1. Stars 47
11.4.2. Emerging Leaders 47
11.4.3. Pervasive Players 47
11.4.4. Participants 47
11.5. Start-ups /SMEs Assessment Metrics, 2023 47
11.5.1. Progressive Companies 47
11.5.2. Responsive Companies 47
11.5.3. Dynamic Companies 47
11.5.4. Starting Blocks 47
11.6. Strategic Developments 48
11.6.1. Acquisitions & Mergers 48
New Product Launch 48
Japan Expansion 48
11.7. Key Players Product Matrix 49
CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 50
12.1. PESTEL 50
12.1.1. Political Factors 50
12.1.2. Economic Factors 50
12.1.3. Social Factors 50
12.1.4. Technological Factors 50
12.1.5. Environmental Factors 50
12.1.6. Legal Factors 50
12.2. Adjacent Market Analysis 50
CHAPTER NO. 13 : PERIODONTAL DISEASE MARKET – BY TYPE SEGMENT ANALYSIS 51
13.1. PERIODONTAL DISEASE Market Overview, by Type Segment 51
13.1.1. PERIODONTAL DISEASE Market Revenue Share, By Type, 2023 & 2032 52
13.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Type 53
13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 53
13.1.4. PERIODONTAL DISEASE Market Revenue, By Type, 2018, 2023, 2027 & 2032 54
13.2. Gingivitis 55
13.3. Chronic Periodontal Disease 56
13.4. Aggressive Periodontal Disease 57
13.5. Type 4 58
13.6. Type 5 59
CHAPTER NO. 14 : PERIODONTAL DISEASE MARKET – BY APPLICATION SEGMENT ANALYSIS 60
14.1. PERIODONTAL DISEASE Market Overview, by Application Segment 60
14.1.1. PERIODONTAL DISEASE Market Revenue Share, By Application, 2023 & 2032 61
14.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Application 62
14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 62
14.1.4. PERIODONTAL DISEASE Market Revenue, By Application, 2018, 2023, 2027 & 2032 63
14.2. Non-surgical Treatment 64
14.3. Surgical Treatment 65
14.4. Application 3 66
14.5. Application 4 67
14.6. Application 5 68
CHAPTER NO. 15 : PERIODONTAL DISEASE MARKET – BY THERAPEUTICS SEGMENT ANALYSIS 69
15.1. PERIODONTAL DISEASE Market Overview, by Therapeutics Segment 69
15.1.1. PERIODONTAL DISEASE Market Revenue Share, By Therapeutics, 2023 & 2032 70
15.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Therapeutics 71
15.1.3. Incremental Revenue Growth Opportunity, by Therapeutics, 2024 – 2032 71
15.1.4. PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018, 2023, 2027 & 2032 72
15.2. Systematic Antibiotics 73
15.3. Local Antibiotics 74
15.4. Therapeutics 3 75
15.5. Therapeutics 4 76
15.6. Therapeutics 5 77
CHAPTER NO. 16 : PERIODONTAL DISEASE MARKET – BY END USERS SEGMENT ANALYSIS 78
16.1. PERIODONTAL DISEASE Market Overview, by End Users Segment 78
16.1.1. PERIODONTAL DISEASE Market Revenue Share, By End Users, 2023 & 2032 79
16.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By End Users 80
16.1.3. Incremental Revenue Growth Opportunity, by End Users, 2024 – 2032 80
16.1.4. PERIODONTAL DISEASE Market Revenue, By End Users, 2018, 2023, 2027 & 2032 81
16.2. Hospitals 82
16.3. Dental Clinic 83
16.4. Dental Academics 84
16.5. Research Institutes and Others 85
16.6. End Users 5 86
CHAPTER NO. 17 : PERIODONTAL DISEASE MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 87
17.1. PERIODONTAL DISEASE Market Overview, by Distribution Channel Segment 87
17.1.1. PERIODONTAL DISEASE Market Revenue Share, By Distribution Channel, 2023 & 2032 88
17.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Distribution Channel 89
17.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 89
17.1.4. PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 90
17.2. Distribution Channel 1 91
17.3. Distribution Channel 2 92
17.4. Distribution Channel 3 93
17.5. Distribution Channel 4 94
17.6. Distribution Channel 5 95
CHAPTER NO. 18 : PERIODONTAL DISEASE MARKET – JAPAN ANALYSIS 96
18.1. Type 96
18.1.1. Japan PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 (USD Million) 96
18.2. Japan PERIODONTAL DISEASE Market Revenue, By Type, 2024 – 2032 (USD Million) 96
18.3. Application 97
18.3.1. Japan PERIODONTAL DISEASE Market Revenue, By Application, 2018 – 2023 (USD Million) 97
18.3.2. Japan PERIODONTAL DISEASE Market Revenue, By Application, 2024 – 2032 (USD Million) 97
18.4. Therapeutics 98
18.4.1. Japan PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018 – 2023 (USD Million) 98
18.4.2. Japan PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2024 – 2032 (USD Million) 98
18.5. End Users 99
18.5.1. Japan PERIODONTAL DISEASE Market Revenue, By End Users, 2018 – 2023 (USD Million) 99
18.5.2. Japan PERIODONTAL DISEASE Market Revenue, By End Users, 2024 – 2032 (USD Million) 99
18.6. Distribution Channel 100
18.6.1. Japan PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 100
18.6.2. Japan PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 100
CHAPTER NO. 19 : COMPANY PROFILES 101
19.1. Bausch Health Companies Inc 101
19.1.1. Company Overview 101
19.1.2. Product Portfolio 101
19.1.3. Swot Analysis 101
19.1.4. Business Strategy 102
19.1.5. Financial Overview 102
19.2. Yoshida Dental Manufacturing Co., Ltd. 103
19.3. Tokyo International Clinic 103
19.4. Lyne Laboratories 103
19.5. WOCKHARDT 103
19.6. DENTSPLY SIRONA Inc 103
19.7. 3M 103
19.8. Amyndas Pharmaceuticals 103
19.9. Biolase, Inc 103
19.10. Company 10 103
19.11. Company 11 103
19.12. Company 12 103
19.13. Company 13 103
19.14. Company 14 103

List of Figures
FIG NO. 1. Japan PERIODONTAL DISEASE Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for Japan PERIODONTAL DISEASE Market 29
FIG NO. 3. Value Chain Analysis for Japan PERIODONTAL DISEASE Market 30
FIG NO. 4. Japan PERIODONTAL DISEASE Market Import Volume/Revenue, By Japan, 2018 – 2023 32
FIG NO. 5. Japan PERIODONTAL DISEASE Market Export Volume/Revenue, By Japan, 2018 – 2023 33
FIG NO. 6. Japan PERIODONTAL DISEASE Market Demand Volume/Revenue, By Japan, 2018 – 2023 34
FIG NO. 7. Japan PERIODONTAL DISEASE Market Supply Volume/Revenue, By Japan, 2018 – 2023 35
FIG NO. 8. Japan PERIODONTAL DISEASE Market Production Volume/Revenue, By Japan, 2018 – 2023 36
FIG NO. 9. Japan PERIODONTAL DISEASE Market Price, By Type, 2018 – 2023 37
FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38
FIG NO. 11. Manufacturing Cost Analysis 39
FIG NO. 12. Manufacturing Process 39
FIG NO. 13. Company Share Analysis, 2023 40
FIG NO. 14. Company Share Analysis, 2023 41
FIG NO. 15. Company Share Analysis, 2023 41
FIG NO. 16. Company Share Analysis, 2023 42
FIG NO. 17. PERIODONTAL DISEASE Market – Company Volume Market Share, 2023 43
FIG NO. 18. PERIODONTAL DISEASE Market – Company Revenue Market Share, 2023 44
FIG NO. 19. PERIODONTAL DISEASE Market Revenue Share, By Type, 2023 & 2032 50
FIG NO. 20. Market Attractiveness Analysis, By Type 51
FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51
FIG NO. 22. PERIODONTAL DISEASE Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
FIG NO. 23. Japan PERIODONTAL DISEASE Market for Gingivitis, Revenue (USD Million) 2018 – 2032 53
FIG NO. 24. Japan PERIODONTAL DISEASE Market for Chronic Periodontal Disease, Revenue (USD Million) 2018 – 2032 54
FIG NO. 25. Japan PERIODONTAL DISEASE Market for Aggressive Periodontal Disease, Revenue (USD Million) 2018 – 2032 55
FIG NO. 26. Japan PERIODONTAL DISEASE Market for Type 4, Revenue (USD Million) 2018 – 2032 56
FIG NO. 27. Japan PERIODONTAL DISEASE Market for Type 5, Revenue (USD Million) 2018 – 2032 57
FIG NO. 28. PERIODONTAL DISEASE Market Revenue Share, By Application, 2023 & 2032 59
FIG NO. 29. Market Attractiveness Analysis, By Application 60
FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60
FIG NO. 31. PERIODONTAL DISEASE Market Revenue, By Application, 2018, 2023, 2027 & 2032 61
FIG NO. 32. Japan PERIODONTAL DISEASE Market for Non-surgical Treatment, Revenue (USD Million) 2018 – 2032 62
FIG NO. 33. Japan PERIODONTAL DISEASE Market for Surgical Treatment, Revenue (USD Million) 2018 – 2032 63
FIG NO. 34. Japan PERIODONTAL DISEASE Market for Application 3, Revenue (USD Million) 2018 – 2032 64
FIG NO. 35. Japan PERIODONTAL DISEASE Market for Application 4, Revenue (USD Million) 2018 – 2032 65
FIG NO. 36. Japan PERIODONTAL DISEASE Market for Application 5, Revenue (USD Million) 2018 – 2032 66
FIG NO. 37. PERIODONTAL DISEASE Market Revenue Share, By Therapeutics, 2023 & 2032 68
FIG NO. 38. Market Attractiveness Analysis, By Therapeutics 69
FIG NO. 39. Incremental Revenue Growth Opportunity by Therapeutics, 2024 – 2032 69
FIG NO. 40. PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018, 2023, 2027 & 2032 70
FIG NO. 41. Japan PERIODONTAL DISEASE Market for Systematic Antibiotics, Revenue (USD Million) 2018 – 2032 71
FIG NO. 42. Japan PERIODONTAL DISEASE Market for Local Antibiotics, Revenue (USD Million) 2018 – 2032 72
FIG NO. 43. Japan PERIODONTAL DISEASE Market for Therapeutics 3, Revenue (USD Million) 2018 – 2032 73
FIG NO. 44. Japan PERIODONTAL DISEASE Market for Therapeutics 4, Revenue (USD Million) 2018 – 2032 74
FIG NO. 45. Japan PERIODONTAL DISEASE Market for Therapeutics 5, Revenue (USD Million) 2018 – 2032 75
FIG NO. 46. PERIODONTAL DISEASE Market Revenue Share, By End Users, 2023 & 2032 77
FIG NO. 47. Market Attractiveness Analysis, By End Users 78
FIG NO. 48. Incremental Revenue Growth Opportunity by End Users, 2024 – 2032 78
FIG NO. 49. PERIODONTAL DISEASE Market Revenue, By End Users, 2018, 2023, 2027 & 2032 79
FIG NO. 50. Japan PERIODONTAL DISEASE Market for Hospitals, Revenue (USD Million) 2018 – 2032 80
FIG NO. 51. Japan PERIODONTAL DISEASE Market for Dental Clinic, Revenue (USD Million) 2018 – 2032 81
FIG NO. 52. Japan PERIODONTAL DISEASE Market for Dental Academics, Revenue (USD Million) 2018 – 2032 82
FIG NO. 53. PERIODONTAL DISEASE Market Revenue Share, By Distribution Channel, 2023 & 2032 84
FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85
FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85
FIG NO. 56. PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86
FIG NO. 57. Japan PERIODONTAL DISEASE Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87
FIG NO. 58. Japan PERIODONTAL DISEASE Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88
FIG NO. 59. Japan PERIODONTAL DISEASE Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89
FIG NO. 60. Japan PERIODONTAL DISEASE Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90
FIG NO. 61. Japan PERIODONTAL DISEASE Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91
FIG NO. 62. Research Methodology – Detailed View 100
FIG NO. 63. Research Methodology 101

List of Tables
TABLE NO. 1. : Japan PERIODONTAL DISEASE Market: Snapshot 18
TABLE NO. 2. : Drivers for the PERIODONTAL DISEASE Market: Impact Analysis 22
TABLE NO. 3. : Restraints for the PERIODONTAL DISEASE Market: Impact Analysis 24
TABLE NO. 4. : Japan PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 34
TABLE NO. 5. : Key Raw Materials & Suppliers 35
TABLE NO. 6. : Japan PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 (USD Million) 89
TABLE NO. 7. : Japan PERIODONTAL DISEASE Market Revenue, By Type, 2024 – 2032 (USD Million) 89
TABLE NO. 8. : Japan PERIODONTAL DISEASE Market Revenue, By Application, 2018 – 2023 (USD Million) 90
TABLE NO. 9. : Japan PERIODONTAL DISEASE Market Revenue, By Application, 2024 – 2032 (USD Million) 90
TABLE NO. 10. : Japan PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018 – 2023 (USD Million) 91
TABLE NO. 11. : Japan PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2024 – 2032 (USD Million) 91
TABLE NO. 12. : Japan PERIODONTAL DISEASE Market Revenue, By End Users, 2018 – 2023 (USD Million) 92
TABLE NO. 13. : Japan PERIODONTAL DISEASE Market Revenue, By End Users, 2024 – 2032 (USD Million) 92
TABLE NO. 14. : Japan PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93
TABLE NO. 15. : Japan PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions:

What is the current size of the Japan Periodontal Disease market?

The Japan periodontal disease market was valued at USD 182.12 million in 2023 and is projected to reach USD 324.70 million by 2032, growing at a compound annual growth rate (CAGR) of 6.41%.

What factors are driving the growth of the Japan Periodontal Disease market?

The market is driven by the aging population, rising prevalence of periodontal diseases, increased awareness of oral health, and advancements in dental care technologies such as laser treatments and regenerative therapies. Favorable healthcare policies, government-supported reimbursement schemes, and a strong focus on preventive care further support market growth.

What are the key segments within the Japan Periodontal Disease market?

The market is segmented by:
• Type: Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, and advanced stages like Type 4 and Type 5.
• Application: Non-surgical treatments (scaling, root planing) and surgical treatments (flap surgery, bone grafting, laser therapies).
• Geography: Key regions include Kanto, Kansai, Chubu, and Kyushu.

What are some challenges faced by the Japan Periodontal Disease market?

Challenges include limited access to specialized care in rural areas, high treatment costs despite government support, and poor patient compliance with long-term maintenance therapies. Additionally, cultural stigma around dental issues and delayed detection of periodontal diseases further hinder market growth.

Who are the major players in the Japan Periodontal Disease market?

Key players include Bausch Health Companies Inc., Yoshida Dental Manufacturing Co., Ltd., Tokyo International Clinic, Lyne Laboratories, WOCKHARDT, DENTSPLY SIRONA Inc., 3M, Amyndas Pharmaceuticals, and Biolase, Inc. These companies focus on providing advanced treatments like laser therapies, regenerative procedures, and personalized periodontal care solutions.

Japan Safety Gloves Market

Published:
Report ID: 68590

Japan VXI Test Equipment Market

Published:
Report ID: 68389

Japan Biopharmaceuticals Contract Manufacturing Market

Published:
Report ID: 68131

Japan Digital Radiography Market

Published:
Report ID: 67945

Japan Data Center Precision Air Conditioning Market

Published:
Report ID: 67941

Japan K-Beauty Product Market

Published:
Report ID: 67628

Japan Polyacrylonitrile Fiber Market

Published:
Report ID: 67364

Japan Contract Cleaning Services Market

Published:
Report ID: 67361

Japan Peritoneal Dialysis Market

Published:
Report ID: 66666

Artificial Urinary Sphincter Market

Published:
Report ID: 69140

Bone Cement Delivery Systems Market

Published:
Report ID: 69120

Mammalian Transient Protein Expression Market

Published:
Report ID: 68859

Fuchs Endothelial Corneal Dystrophy (FECD) Market

Published:
Report ID: 68772

Mastectomy Reconstruction Implants Market

Published:
Report ID: 68643

Anti-Neoplastic Pharmaceutical Agents Market

Published:
Report ID: 68630

Major Depressive Disorder Treatment Market

Published:
Report ID: 68629

Japan Biopharmaceuticals Contract Manufacturing Market

Published:
Report ID: 68131

Malaysia Biopharmaceuticals Contract Manufacturing Market

Published:
Report ID: 67948

Injectable Potassium Phosphate Market

Published:
Report ID: 67907

Laboratory Benchtop Automation Market

Published:
Report ID: 67895

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$5699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN